Search
for
Sort by
Research 391–420 of 486
- Mechanisms of autophagy and their implications in dermatological disorders
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Retinoids in Dermatology
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Monkeypox: A Histopathological and Transmission Electron Microscopy Study
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- A review of the botany, ethnopharmacology, phytochemistry, pharmacology, toxicology and quality of Anemarrhena asphodeloides Bunge
- Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Teneligliptin-induced hair loss: A case report
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Muscle weakness of the lower limbs after epidural anesthesia in a pregnant woman with undiscovered systemic lupus erythematosus
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Medical Dermatology
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study
- Long- COVID and general health status in hospitalized COVID-19 survivors